{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:07:50Z","timestamp":1791216470284,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Showalter Research Trust Fund"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA168814"],"award-info":[{"award-number":["R01CA168814"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD074587"],"award-info":[{"award-number":["R01HD074587"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54HD090215"],"award-info":[{"award-number":["U54HD090215"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia & Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.cll.2018.10.005","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T01:44:48Z","timestamp":1545097488000},"page":"61-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Biomarkers for Early Complications After Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"39","author":[{"given":"Courtney M.","family":"Rowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Paczesny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.cll.2018.10.005_bib1","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.cll.2018.10.005_bib2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bbmt.2015.01.003","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: III. The 2014 Biomarker Working Group report","volume":"21","author":"Paczesny","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.cll.2018.10.005_bib3","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2004-03-0803","article-title":"Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome","volume":"104","author":"Flomenberg","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cll.2018.10.005_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2016-09-737700","article-title":"Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease","volume":"129","author":"Martin","year":"2017","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.cll.2018.10.005_bib5","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/blood-2017-05-784637","article-title":"Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant","volume":"130","author":"Karaesmen","year":"2017","journal-title":"Blood"},{"issue":"408","key":"10.1016\/j.cll.2018.10.005_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan3085","article-title":"Combined OX40L and mTOR blockade controls effector T\u00a0cell activation while preserving Treg reconstitution after transplant","volume":"9","author":"Tkachev","year":"2017","journal-title":"Sci Transl Med"},{"issue":"13","key":"10.1016\/j.cll.2018.10.005_bib7","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1470-2045(14)71017-4","article-title":"Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1\/2 trial","volume":"15","author":"Kennedy","year":"2014","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.cll.2018.10.005_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2015-03-636753","article-title":"Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment","volume":"126","author":"McDonald","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2018.10.005_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood-2008-07-167098","article-title":"A\u00a0biomarker panel for acute graft-versus-host disease","volume":"113","author":"Paczesny","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cll.2018.10.005_bib10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2009-03-212290","article-title":"Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network","volume":"114","author":"Alousi","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2018.10.005_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood-2014-06-584789","article-title":"High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation","volume":"125","author":"Ponce","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2018.10.005_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3324\/haematol.2016.152322","article-title":"Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide","volume":"102","author":"Kanakry","year":"2017","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.cll.2018.10.005_bib13","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.bbmt.2014.06.039","article-title":"Prognostic biomarkers for acute graft-versus-host disease risk after cyclophosphamide-fludarabine nonmyeloablative allotransplantation","volume":"20","author":"Nelson","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.cll.2018.10.005_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cll.2018.10.005_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood-2016-08-735324","article-title":"Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT","volume":"129","author":"Abu Zaid","year":"2017","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.cll.2018.10.005_bib16","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1182\/blood-2018-01-822957","article-title":"MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD","volume":"131","author":"Major-Monfried","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cll.2018.10.005_bib17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbmt.2017.04.029","article-title":"Predictive value of clinical findings and plasma biomarkers after fourteen days of prednisone treatment for acute graft-versus-host disease","volume":"23","author":"McDonald","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.cll.2018.10.005_bib18","doi-asserted-by":"crossref","first-page":"e89798","DOI":"10.1172\/jci.insight.89798","article-title":"An early-biomarker algorithm predicts lethal graft-versus-host disease and survival","volume":"2","author":"Hartwell","year":"2017","journal-title":"JCI Insight"},{"issue":"308","key":"10.1016\/j.cll.2018.10.005_bib19","doi-asserted-by":"crossref","first-page":"308ra160","DOI":"10.1126\/scitranslmed.aab0166","article-title":"ST2 blockade reduces sST2-producing T\u00a0cells while maintaining protective mST2-expressing T\u00a0cells during graft-versus-host disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci Transl Med"},{"issue":"21","key":"10.1016\/j.cll.2018.10.005_bib20","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1182\/blood-2011-11-389304","article-title":"Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation","volume":"119","author":"Chaidos","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cll.2018.10.005_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbmt.2010.02.026","article-title":"Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T\u00a0cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease","volume":"16","author":"Magenau","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.cll.2018.10.005_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86660","article-title":"Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease","volume":"1","author":"Li","year":"2016","journal-title":"JCI insight"},{"issue":"3","key":"10.1016\/j.cll.2018.10.005_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1182\/blood-2012-03-415422","article-title":"Expression of CD30 in patients with acute graft-versus-host disease","volume":"120","author":"Chen","year":"2012","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.cll.2018.10.005_bib24","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1182\/blood-2017-03-772210","article-title":"Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host disease","volume":"129","author":"Chen","year":"2017","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.cll.2018.10.005_bib25","doi-asserted-by":"crossref","first-page":"13ra12","DOI":"10.1126\/scitranslmed.3000406","article-title":"Elafin is a biomarker of graft-versus-host disease of the skin","volume":"2","author":"Paczesny","year":"2010","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.cll.2018.10.005_bib26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.bbmt.2013.06.011","article-title":"A\u00a0novel soluble form of Tim-3 associated with severe graft-versus-host disease","volume":"19","author":"Hansen","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.cll.2018.10.005_bib27","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2011-10-387357","article-title":"Plasma biomarkers of lower gastrointestinal and liver acute GVHD","volume":"119","author":"Harris","year":"2012","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.cll.2018.10.005_bib28","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1182\/blood-2011-08-375006","article-title":"Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease","volume":"118","author":"Ferrara","year":"2011","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.cll.2018.10.005_bib29","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/bloodadvances.2018017343","article-title":"Amphiregulin modifies the Minnesota acute graft-versus-host disease risk score: results from BMT CTN 0302\/0802","volume":"2","author":"Holtan","year":"2018","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.cll.2018.10.005_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.cll.2018.10.005_bib31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bmt.1701445","article-title":"Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study","volume":"22","author":"Lee","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.cll.2018.10.005_bib32","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1046\/j.1365-2141.2002.03748.x","article-title":"Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide","volume":"118","author":"Lee","year":"2002","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.cll.2018.10.005_bib33","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.bbmt.2010.02.016","article-title":"Prediction of veno-occlusive disease using biomarkers of endothelial injury","volume":"16","author":"Cutler","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.cll.2018.10.005_bib34","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.bbmt.2015.07.004","article-title":"Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation","volume":"21","author":"Akil","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.cll.2018.10.005_bib35","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.bbmt.2017.11.039","article-title":"Diagnostic and prognostic plasma biomarkers for idiopathic pneumonia syndrome after hematopoietic cell transplantation","volume":"24","author":"Seo","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.cll.2018.10.005_bib36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/PCC.0000000000000673","article-title":"Invasive mechanical ventilation and mortality in pediatric hematopoietic stem cell transplantation: a multicenter study","volume":"17","author":"Rowan","year":"2016","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"10.1016\/j.cll.2018.10.005_bib37","doi-asserted-by":"crossref","first-page":"S301","DOI":"10.1016\/j.bbmt.2017.12.345","article-title":"Prognostic and predictive biomarkers for respiratory failure and related mortality post allogeneic hematopoietic cell transplantation","volume":"24","author":"Rowan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.cll.2018.10.005_bib38","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbmt.2009.05.010","article-title":"Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation","volume":"15","author":"Majhail","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.cll.2018.10.005_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10753-012-9533-7","article-title":"Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease","volume":"36","author":"Gebremedhin","year":"2013","journal-title":"Inflammation"},{"issue":"7","key":"10.1016\/j.cll.2018.10.005_bib40","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/01.tp.0000296482.50994.1c","article-title":"Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation","volume":"84","author":"Fuji","year":"2007","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cll.2018.10.005_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbmt.2016.12.627","article-title":"Metabolic complications precede alloreactivity and are characterized by changes in suppression of tumorigenicity 2 signaling","volume":"23","author":"Johnpulle","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cll.2018.10.005_bib42","unstructured":"Teagarden AM, Moser E, Rowan CM, et\u00a0al. Early ST2 levels are associated with the diagnosis of post-transplant diabetes mellitus. Paper presented at: Pediatric Academic Society 2018; Toronto, Canda."},{"issue":"4","key":"10.1016\/j.cll.2018.10.005_bib43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cll.2018.10.005_bib44","first-page":"181","article-title":"Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment","volume":"7","author":"Rosenthal","year":"2016","journal-title":"J\u00a0Blood Med"},{"issue":"12","key":"10.1016\/j.cll.2018.10.005_bib45","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMc1700185","article-title":"ST2 and endothelial injury as a link between GVHD and microangiopathy","volume":"376","author":"Rotz","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cll.2018.10.005_bib46","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3026(14)00035-0","article-title":"A\u00a0prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study","volume":"2","author":"Levine","year":"2015","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.cll.2018.10.005_bib47","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/jid.2014.489","article-title":"Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease","volume":"135","author":"Bruggen","year":"2015","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271218312010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271218312010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:56:41Z","timestamp":1759449401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271218312010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0272271218312010"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2018.10.005","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers for Early Complications After Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}